Rachel Perrin

752 citations
13 papers · 573 indexed · h-index 10
Topics
Pharmacogenetics and Drug Metabolism (5 papers)Drug Transport and Resistance Mechanisms (3 papers)Alzheimer's disease research and treatments (2 papers)

In The Last Decade

Rachel Perrin

13 papers receiving 560 citations

Peers

Rachel Perrin
Comparison fields: 5 of 86
  • Molecular Biology 190
  • Oncology 137
  • Pharmacology 118
  • Physiology 98
  • Pulmonary and Respiratory Medicine 93
Replace C. Rochette with:
C. Rochette Canada
Yuji Ohno Japan
Pontus Forsell Sweden
Changju Song United States
Richard J. Heaslip United States
R Charest United States
K.R. Hunter United Kingdom
Cunjin Su China
Cosimo Walter D’Acunto Italy
Emel Songu‐Mize United States
Rachel Perrin relative to C. Rochette Canada C. Rochette's profile →
Citations per field
00.5×3.9×
C. Rochette · 1×
Citations per year

Countries citing papers authored by Rachel Perrin

Since Specialization
Citations

This map shows the geographic impact of Rachel Perrin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Perrin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Perrin more than expected).

Fields of papers citing papers by Rachel Perrin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Perrin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Perrin. The network helps show where Rachel Perrin may publish in the future.

Co-authorship network of co-authors of Rachel Perrin

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Perrin. A scholar is included among the top collaborators of Rachel Perrin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Perrin. Rachel Perrin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
#WorkIndexed citations
1 10
2 3
3 105
4 85
5 2
6 27
7 134
8 5
9 50
10 70
11 57
12 16
13 9

About Rachel Perrin

Rachel Perrin is a scholar working on Pharmacology, Biochemistry and Pharmaceutical Science, having authored 13 papers that have together received 573 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (5 papers), Drug Transport and Resistance Mechanisms (3 papers) and Alzheimer's disease research and treatments (2 papers). The work is most often cited by research in Pharmacology (118 citations), Biochemistry (69 citations) and Neurology (43 citations). Rachel Perrin has collaborated with scholars based in France, Canada and United Kingdom. Frequent co-authors include Alain Minn, Gérard Siest, Jean‐François Ghersi‐Egea, Claude Jeandel, H. Barton Grossman, Robert McBroom, Fernando Saldías P, R W Mercer, Serge Briançon and Joseph Zabner. Their work appears in journals such as Journal of Clinical Investigation, Clinical Orthopaedics and Related Research and Brain Research Reviews.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026